Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03943134 · ClinicalTrials.gov registry record
Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity
A clinical trial, sponsored by Axogen Corporation.
- Terminated
- Registry status
- 7
- Enrollment target
NCT03943134: Clinical Trial study, sponsored by Axogen Corporation.
NCT03943134 is a clinical trial that was terminated before completion, run by Axogen Corporation. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03943134 was terminated before completion, sponsored by Axogen Corporation.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
A registry study to evaluate the role of Avive® Soft Tissue Membrane in the management of nerve injury associated with acute trauma in the upper extremity.
Primary Outcome
Adult patients will be assessed for changes in functional status using the QuickDASH outcomes assessment. The quickDASH is an abbreviated version of the original DASH outcomes measures and is comprised of an 11-item patient reported questionnaire used to assess physical function and severity of symptoms in patients with musculoskeletal disorders of the upper limb. Each of the items in the quickDASH use a 5-point Likert scale to assess the corresponding severity or functional parameter. The outco
Interventions
- OTHER Minimally Processed Human Umbilical Cord Membrane
- OTHER Standard Surgical Procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-12-01 |
| Est. Completion | 2020-12-17 |
Why NCT03943134 stopped before completion
NCT03943134 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Minimally Processed Human Umbilical Cord Membrane is the first listed.
NCT03943134 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03943134 about?
NCT03943134 is a clinical study titled "Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity". A registry study to evaluate the role of Avive® Soft Tissue Membrane in the management of nerve injury associated with acute trauma in the upper extremity.
What is the current status of trial NCT03943134?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2018-12-01. Estimated completion is 2020-12-17.
What interventions are being tested in trial NCT03943134?
The interventions under investigation include: Minimally Processed Human Umbilical Cord Membrane (OTHER), Standard Surgical Procedures (OTHER).
Who is sponsoring clinical trial NCT03943134?
This trial is sponsored by Axogen Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI